Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I hope Pro140 can work. We have a very serious issue at hand.
Thanks for insight! What should I do next ?
Given the bloodbath and distractions out there CYDY held up great today.
With the world events unfolding there is no reason anyone else except us shareholders would have heard about or reacted to a minor OTC PR on a corona IND or at CROI. All too attentive to much bigger and family safety issues: Italy shut down; CA, OR, NY in states of emergency; busy rearranging spring break for the kids as school trips and volunteering jobs are that just got cancelled; no business travel or meetings as no one wants to see me, nor I them. Do we go out to dinner and support friends who own businesses? Certainly would like to visit the nursing home this week, but ....
In 30 days, in a 1 year all will be very interesting. Hope some folks took my advice on SPXS- up 20% today.
March 6, 2020, IMPORTANT CROI UPDATE: CROI WILL BE VIRTUAL
CROI leadership has continued to monitor the growing COVID-19 outbreak in the US and globally each day. Many countries, agencies, and institutions have now banned travel, and many infectious disease physicians are urgently needed to care for patients with COVID-19 in their own institutions. Because of increasing concerns that travel to a large group gathering like CROI is not advisable from a personal and public health perspective, the CROI leadership has come to the difficult decision that the 2020 CROI meeting will be virtual."
https://www.croiconference.org/
The short play today, like all week is SPXS. Up 60k so far.
Stoked to see where we will be EOM and EOY. A buy out for a stock swap into GILD would be fine with me as I know they know what to do with this drug, have the chops to do it and its a tax free event.
Fug. Another crappy start. Hope he pulls out the rabbit.
Make the long story it shorter. OMG, I have had to mute 6 times already.
Happy for you! Capitalism is F-ing awesome!
Another great buy opportunity.
Buy the CYDY dips. Under $1 is a nice op for investors. Q2-20 will be a very interesting time.
Looking for trading fun? SPXS is a thrill. Up 10% trading that this a.m.
Yup.
dang, ya beat me- more at 85
If your holding a short of CYDY over this weekend you are one crazy MF.
gotta agree- a nicer buy op than yesterday for those who want in.
from post 55312: (thank you S Smith for this!)
"Total of 6 patients enrolled to date.
Results from 4 patients so far.
Pt 1) Injected in Sept 27. 2 weeks CTC went from 5 to 0 copy/ml. Next three months CTC remained zero.
P2 (MIL) June 27, 2019, metastasis to brain. Main tumor reduced 56% once on LERO.
Pt 3: Injected Jan 7. 2 weeks CTC from 9 to 2.
Pt 4: Jan 2. CAML reduced from 45 to 30." (my emphasis)
Note: Cancer-Associated Macrophage-like Cells (CAML) are not CTCs. I think it may be a few days too early for the CTC reporting, idk- anyone?.
"CAMLs are more prevalent than CTCs in many solid tumor subtypes, and unlike CTCs, CAMLs are found in all stages of solid tumors 6-10. Combined, our data suggest that CAMLs and CTCs isolated from the same patient blood sample provide more robust clinical utility than CTCs alone." https://onlinelibrary.wiley.com/doi/full/10.1002/cyto.a.23573
Another good article: Size matters!
https://cancerres.aacrjournals.org/content/78/13_Supplement/2631
Post # 55312 has best synopsis of call. All good news to me.
Bot a few more shares at 1.39 to 1.31 for lunch money next week.
Great call BECAUSE IT INVOLVED A TEAM! Not just NP.
BLA delay, well duh, its Feb 6th. 3 weeks from now- ok, delays happen all the time, its business. We all know NP over hopes. Swing in stock- good thing- 1.65 came awful fast, a little consolidation is just a buying opportunity for your friends and family to get in on this thing.
The IMPORTANT STUFF:
4 patients with stunning cancer results, 3 more lined up for injection shortly and 3 more within 3 weeks. So in next 5 weeks, we could have initial results on 10 patients. Think about that.... just a bit. Now, do you really care if the BLA is now or Feb 28th given that you bot an HIV indication and now its a potential cancer blockbuster?
I am thrilled the MOA is seriosuly being looked at and may help with the 28K confirmed corona virus patients. Hmmm, didn't NP say something about a SIGNED agreement?
imho
nice trade
Sinopharm Group: The Group is considered the largest wholesaler and retailer of pharmaceutical and healthcare products in China, as well as a leading supply-chain service provider. Nov 8, 2019
https://www.bizvibe.com/blog/pharmaceuticals-and-biotechnology/top-10-pharmaceutical-companies-china/
Nice week folks. I appreciate the company in this amazing journey.
Feb: National Cancer Prevention Month
Feb 4: World Cancer Day
https://www.cancer.net/research-and-advocacy/cancer-awareness-dates
Here we hope for many.
JA2: I love that people are trading this stock. This is capitalism: buy low sell high. More eyeballs, smarter players, volumes, volatility, media, uplift.
I am here to make dough and I have a very solid base position in CYDY. And when I see opportunity to trade, swing, short in any stock, I consider it.
Yesterday was excellent example and I just paid the mortgage for 2 months with it. We all knew data was coming out this week on cancer patients- public knowledge. Hit 1.54 Thursday - wow! - then slammed to 1.24. Dang, that's an op. I bot 25k at 1.25 sold it today between 1.41 and 1.47.
And I was paying too much attention this a.m. to CYDY to trade AMZN. fug. That was a no brainier too.
Welcome to the rodeo. Great moves today. Trading like this on OTC- Yehaa! Interest is stirring when 8.4M shares trade (~ $11M, nice) and this kind of fluctuation . Bigger retail folks stepping in. Docs with $4M in portfolios can easily throw $250k this way. I think more than a few are.
Nice sell opportunity this a.m. and buy-back opportunity this p.m. today if ya got brass testes or ovaries.
Awaiting patient's updates patiently. Up-list now firmly on visible horizon with solid news afoot.
Please.
Ask again in June. Maybe take $3k off the table and go surfing in Costa Rica. No more. In June my bet is you will be quite happy with cydy. Maybe go back to Costa Rica again and maybe stay a lot longer.
Just changed my mind. If you have $50k in this high risk otc and then you know your sh*t. Buy more today and ride that from 1.30 to whatever makes you feel good. Leave the 100k shares alone.
DrugDr: thanks for the warning! I would have never known. Please continue with your thoughtful and well researched insights. I'll just keep away from stocks altogether because risk never gets rewarded.
Patience grasshopper, you are wise...
Kook: Yup, BLA submission is a huge deal. I think FDA will guide CYDY on additional indications if we get cancer results anywhere near what we see in pre-clinical prior to BLA approval.
But what do I know how the FDA works? Just another bozo on the bus with an opinion. And a fun size block of shares to put money where my mouth is. And getting funner.
A17/Ohm20 - BLA filing is a huge deal and I do not believe it is priced in. Not for me anyway. Because we are aware does not mean others are: 1/3 is not 3/3. It's a major milestone for a drug to get. It will garner broader attention. I am stoked to have that app in, more so to get approved!
60 Million shares traded in the last month. Serious money piling in. Things are gonna pop. Sheet in, winds freshening!
Guess I may have to ship Depends to FDA as well.
Saltz- I am ordering Depends be shipped out today for both of us right now just in case.
Exactly my point, Bulldog, we want the best, but how do you know who is best if you only have males making decisions?
These guys have not YET included many females in the process, so how can I believe that they have found the best? My point: Kudos on the new attorney. Hope she brings some smart women along and brings the resources of half the population along with her. Cytodyn needs a dynamic team for the execution challenges ahead.
Again: "35 percent higher return on equity and 34 percent higher total shareholder return than male-dominated firms". Good business and investment practice to break out of the mold of thinking what the "the best" means. If more females means higher equity and shareholder return, isn't that best?
The world is changing my friends and I, as a 60 year old privileged white guy, am just trying to search for enlightenment, to be here now.
I want to see females on BOD and key executive positions at CYDY. This is an echo-chamber of old guys.
“We find clear evidence that companies with a higher proportion of women in decision-making roles continue to generate higher returns on equity while running more conservative balance sheets,” according to a 2016 report from Credit Suisse. “In fact, where women account for the majority in the top management, the businesses show superior sales growth, high cash flow returns on investments and lower leverage.” -
"A review of 353 Fortune 500 companies by the non-profit group Catalyst showed that companies with high representations of women in their senior leadership teams had a 35 percent higher return on equity and 34 percent higher total shareholder return than male-dominated firms."
https://www.thebalance.com/do-companies-with-female-executives-perform-better-4586443
No issues there Zuess! I am stoked for CYDY to start saving lives and financing is key to get these next indications going and to help out the 50-60 Right to Try patients that have lined up, desperate for help.
Did I hear it was DEBT financing that NP mentioned on call?
Hey SJ: Devils in the details. I hope, actually, I believe next year we will be at the JPM Conf!
Sorry to throw some cold water on that enthusiasm Zuess but JP Morgan (and all banks) VP's are a dime a dozen. And CYDY was at Biotech Showcase not at the JP Morgan conference. Same town, same time. Not the same thing. As JPM client I had access to go to the JMP conf, but declined as CYDY would not be there.
https://informaconnect.com/biotech-showcase/ (CYDY here)
https://www.jpmorgan.com/global/healthcare-conference
Webcast at 10.30 PST from BioTech Showcase Conference:
https://www.cytodyn.com/newsroom/press-releases (click on and register)
Is this CYDY in an hour?
Adaptimmune Soars 250% On Positive Initial Responses For T-Cell Platform In 4 Tumor TypesToday 12:50 PM ET (Benzinga)Print
Shares of smid-cap biotech Adaptimmune Therapeutics PLC – ADR (NASDAQ: ADAP) were skyrocketing Monday following a presentation at the 38th JPMorgan Healthcare Conference.
Fair warning shorters.
Fantastic news for the 2 new patients in the TNBC study. Heart out to them. Interim results in 3 weeks. Hopes for the the same amazing path towards recovery seen in the first two patients.
This product will be on the market later this year for HIV-combo therapy and if these results come in as expected off-label demand will blow away HIV demand.
Wild ride ahead!